Scientific fraud forms basis for Alzheimer's company ATHA, according to allegations. Western blot tests appear to have been altered. That's okay, it's a mere $400 million that they raised. Fortunately their lead drug candidate is NOT the one that the founder developed, but is a different molecule, and it seems like the hypothesis still has merit.

This was a non-amyloid theory company. I hope that this one person's possible fraud does not affect the way other non-amyloid companies are viewed.

https://endpts.com/biotech-founder-placed-on-...-scrutiny/